Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency – Interim Final Rule Summary
HFMA presents a comprehensive summary of the interim final rule with comment period providing for additional policy and regulatory revisions in response to the COVID-19 public health emergency.
COVID-19 exacerbates bankruptcy for at-risk hospitals
HFMA's Chad Mulvany says there will be a greater number of hospital bankruptcies the longer Congress and the administration dither on additional relief to providers and if more providers have to reduce the volume of non-emergent services due to spiking COVID-19 cases.
COVID-19 interim final rule focus: Increased Medicare payment for qualifying COVID-19 treatment
HFMA's Chad Mulvany says HFMA believes CMS should modify the NCTAP payment as HFMA is concerned that payment methodology will not cover the cost of qualifying new COVID-19 treatments provided to Medicare beneficiaries.
Physicians score well in Quality Payment Program but receive little for it
HFMA's Chad Mulvany says the Merit-based Incentive Payment System (MIPS) program needs to be simplified to allow all providers to participate without it being overly burdensome.
Health Plan Price Transparency Requirements Final Rule Executive Summary
HFMA presents a summary of a final rule released by CMS requiring health plans to make an online price transparency tool that provides cost sharing and other information available to their members.
For hospitals, Biden’s healthcare policies include many unknowns
Presidential front-runner Joe Biden has far-reaching healthcare policy proposals, but many details and outcomes remain unknown.
CMS finalizes requirement for hospitals to report MA plan rates
In the FY21 IPPS final rule, CMS expanded controversial negotiated-price reporting requirements.
Hospital finance leaders expect deteriorating payer mix, HFMA survey finds
Most hospitals expect their payer mix to shift in the next 12 months toward more Medicaid and individually insured patients.
Hospitals’ challenge to new transparency rule draws skepticism from appeals court
A federal appeals panel appeared hostile to many hospital arguments in a case challenging a looming price transparency requirement.
Requirements for drug price information added to final rule on health plan price transparency
Health plans are required by a new final rule to publicly release negotiated rates with all providers and give enrollees out-of-pocket cost information for each.